Friday, 15 December 2023

Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients

A drug that targets the deadliest form of breast cancer has recently been found to elicit no side effects, and triggered an immune response in 75% of patients. Conducted at the Cleveland Clinic with funding from the Pentagon, the vaccine was administered to 16 women in three separate doses. The form of the vaccine that […]

The post Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients appeared first on Good News Network.



from Good News Network https://ift.tt/3Db1KJv
via IFTTT

No comments: